Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up
- 1 June 1989
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 51 (6) , 951-956
- https://doi.org/10.1016/s0015-0282(16)60724-0
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Regression of uterine leiomyomas after treatment with gestrinone, an antiestrogen, antiprogesteroneAmerican Journal of Obstetrics and Gynecology, 1986
- Long-acting gonadotropin hormone-releasing hormone analogused to treat uteriFertility and Sterility, 1986
- Shrinkage of a uterine fibroid after subcutaneous infusion of a LHRH agonist.BMJ, 1984
- Regression of leiomyomata uteri following hypoestrogenism induced by repetitive luteinizing hormone-releasing hormone agonist treatment: preliminary reportFertility and Sterility, 1984
- Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.BMJ, 1984
- Effects Of The (imBzl)D-His6, Des-Gly Analog Of GnRh On Gonadotropin And Estradiol Secretion In Normal WomenEndocrine Research, 1984
- A conservative approach to the management of uterine leiomyoma: Pituitary desensitization by a luteinizing hormone-releasing hormone analogueAmerican Journal of Obstetrics and Gynecology, 1983
- Leiomyomas: Steroid receptor contentAmerican Journal of Obstetrics and Gynecology, 1982
- Uterine leiomyomata: etiology, symptomatology, and managementFertility and Sterility, 1981
- Induction of degenerative changes in uterine myomas by high-dosage progestin therapyAmerican Journal of Obstetrics and Gynecology, 1966